drugset / Trial / NCT00992290
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Phase 1
Completed
37 enrolled
Virginia Commonwealth University
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This research proposes to find whether the probiotic lactobacillus GG is safe and well tolerated in patients with minimal hepatic encephalopathy. We also want to get insight into the mechanisms of action of LGG.
Timeline
- Start
- 2009-10
- Primary completion
- 2012-12
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus GG | Other / unclassified | 1 unknown | — |